Leptin-induced Endothelial Dysfunction in Obesity
Overview
Physiology
Affiliations
Hyperleptinemia accompanying obesity affects endothelial nitric oxide (NO) and is a serious factor for vascular disorders. NO, superoxide (O(2)(-)), and peroxynitrite (ONOO(-)) nanosensors were placed near the surface (5+/-2 microm) of a single human umbilical vein endothelial cell (HUVEC) exposed to leptin or aortic endothelium of obese C57BL/6J mice, and concentrations of calcium ionophore (CaI)-stimulated NO, O(2)(-), ONOO(-) were recorded. Endothelial NO synthase (eNOS) expression and L-arginine concentrations in HUVEC and aortic endothelium were measured. Leptin did not directly stimulate NO, O(2)(-), or ONOO(-) release from HUVEC. However, a 12-h exposure of HUVEC to leptin increased eNOS expression and CaI-stimulated NO (625+/-30 vs. 500+/-24 nmol/l control) and dramatically increased cytotoxic O(2)(-) and ONOO(-) levels. The [NO]-to-[ONOO(-)] ratio ([NO]/[ONOO(-)]) decreased from 2.0+/-0.1 in normal to 1.30+/-0.1 in leptin-induced dysfunctional endothelium. In obese mice, a 2.5-fold increase in leptin concentration coincided with 100% increase in eNOS and about 30% decrease in intracellular L-arginine. The increased eNOS expression and a reduced l-arginine content led to eNOS uncoupling, a reduction in bioavailable NO (250+/-10 vs. 420+/-12 nmol/l control), and an elevated concentration of O(2)(-) (240%) and ONOO(-) (70%). L-Arginine and sepiapterin supplementation reversed eNOS uncoupling and partially restored [NO]/[ONOO(-)] balance in obese mice. In obesity, leptin increases eNOS expression and decreases intracellular l-arginine, resulting in eNOS an uncoupling and depletion of endothelial NO and an increase of cytotoxic ONOO(-). Hyperleptinemia triggers an endothelial NO/ONOO(-) imbalance characteristic of dysfunctional endothelium observed in other vascular disorders, i.e., atherosclerosis and diabetes.
Multifaced roles of adipokines in endothelial cell function.
Yan Y, Wang L, Zhong N, Wen D, Liu L Front Endocrinol (Lausanne). 2024; 15:1490143.
PMID: 39558976 PMC: 11570283. DOI: 10.3389/fendo.2024.1490143.
Rigamonti A, Rubino F, Caroli D, Bondesan A, Mai S, Cella S J Clin Med. 2024; 13(17).
PMID: 39274429 PMC: 11396206. DOI: 10.3390/jcm13175216.
The Roles of Obesity and ASB4 in Preeclampsia Pathogenesis.
Wang Y, Ssengonzi R, Townley-Tilson W, Kayashima Y, Maeda-Smithies N, Li F Int J Mol Sci. 2024; 25(16).
PMID: 39201703 PMC: 11354233. DOI: 10.3390/ijms25169017.
Diaba-Nuhoho P, Mittag J, Brunssen C, Morawietz H, Brendel H Antioxidants (Basel). 2024; 13(5).
PMID: 38790608 PMC: 11118120. DOI: 10.3390/antiox13050503.
Viegas A, Santos T, Nobre J, Dos Santos J, Lage V, Fernandes A BMC Public Health. 2023; 23(1):2353.
PMID: 38017390 PMC: 10683275. DOI: 10.1186/s12889-023-17295-y.